A molybdenum-ciprofloxacin complex with an isopolyoxometalate having DNA binding and antibacterial activity

Guihua Zou,Yulong Zou,Haiyan Li,Weidong Song,Xingang Cui,Zhimin Na,Guangzhi Shen
DOI: https://doi.org/10.1080/00958972.2024.2327634
2024-03-13
Journal of Coordination Chemistry
Abstract:In this study, an antibacterial complex based on the quinolone antibacterial drug ciprofloxacin (CF) and a polyoxometalate was synthesized, Mo 2 O 5 (CF) 2 (CFd) 2 ( β -Mo 8 O 26 )·5H 2 O ( 1 ). Complex 1 was characterized by elemental analysis and X-ray single-crystal diffraction. Single-crystal structural analysis revealed that 1 was made of β -Mo 8 clusters, binuclear molybdenum clusters Mo 2 O 5 (CF) 2 (CFd) 2 , and water molecules. The antibacterial activity of 1 has been tested against three microorganisms ( Staphylococcus aureus , Escherichia coli , and Bacillus subtilis strains); the antibacterial activities of 1 were higher than those of free CF at the same mass amounts. The interaction between 1 and calf thymus DNA (CT-DNA) was investigated using Uv-vis spectroscopy to determine the binding constants. The results indicated that intercalation is the probable mode of action, with 1 demonstrating higher binding constants ( K b ) to CT-DNA (1.8 × 10 5 M −1 ) compared to pure CF (4.9 × 10 4 M −1 ). These findings show that the implementation of molybdate for ciprofloxacin modification resulted in the formation of a metal complex with enhanced antibacterial activity over CF and significantly improving its binding affinity to DNA.
chemistry, inorganic & nuclear
What problem does this paper attempt to address?